Homoeoepathic management of Maladaptive Behaviors in Children with Autism Spectrum

Effectiveness Of Individualized Homoeopathic medicines in reducing Maladaptive behaviors of Children with Autism Spectrum Disorder - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073265

Enrollment

Registered

2024-09-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Individualized Homoeopathic Medicines: The selection of medicine will be based on homoeopathic principles. Appropriate individualized medicine will be given. The medicine potency rang

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases diagnosed as Childhood Autism as per DSM-V Criteria. 2.Children in the age group of 3 to 14 years 3.Children of any gender 3.Children with AMBS score greater than 155

Exclusion criteria

Exclusion criteria: 1.Children with ADHD, ODD, ID and other childhood behavioral disorders 2.Children with congenital disorders and other serious medical illness 3. Children with AMBS score 284 and above

Design outcomes

Primary

Measure	Time frame
To determine the effectiveness of individualized homoeopathic medicines in reducing the maladaptive behaviors in children with autism spectrum disorder (ASD) using Autism Maladaptive Behavior Scale (AMBS).Timepoint: every month till the conclusion of study(12th month)	—

Secondary

Measure	Time frame
To compare the most predominant maladaptive behaviors presented in the study using AMBS scale.Timepoint: every month till the conclusion of study(12th month)	—

Countries

India

Contacts

Public ContactDrMGnnanaprakasham

National Homoeopathy Research Institute In Mental Health

drgprakashpsy@gmail.com9444701176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026